Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose

Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose

Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Revised 8/96

TERUFLEX® BLOOD BAG SYSTEM
CPD/OPTISOL® SOLUTION

Read these instructions before use.

INSTRUCTIONS FOR BLOOD COLLECTION: Use aseptic technique
1. Confirm that all numbered tubing of each blood bag unit contains segment numbers.
2. Make a loose knot in the donor tubing approximately 10 cm from needle unless alternate methods are used to seal tubing.
3. Clamp donor tubing.
4. Suspend primary bag as far as possible below the donor’s arm.
5. Apply blood pressure cuff or tourniquiet to donor's arm. Disinfect site of phlebotomy. If blood pressure cuff is used, inflate cuff to 60 mmHg.
6. Remove needle protector and perform phlebotomy. Remove clamp to permit blood flow into primary bag.
CAUTION Do not touch needle after removing the needle protector.
7. Appropriately secure donor tubing to donor’s arm.
8. MIX BLOOD WITH ANTICOAGULANT AT SEVERAL INTERVALS DURING COLLECTION.
9. Collect labeled volume of blood (+/- 10%).
10. Tighten knot firmly after collection. Clamp between knot and needle. Sever donor tubing between knot and clamp. Collect blood samples.
11. Reapply clamp to donor tubing; release pressure on donor's arm and remove needle. Seal donor tubing.
CAUTION Discard tubing/phlebotomy needle unit according to institutional procedures.
12. Immediately after collection, invert bag several times to assure blood and anticoagulant are well mixed.
13. Strip blood from donor tubing into bag, mix well, and allow tubing to refill. Seal on or near X marks on donor tubing to provide numbered aliquots of anticoagulated blood for testing.
14. Centrifuge unit to separate red cells from plasma.
15.The time of addition of OPTISOL Solution may vary depending on the processing option selected. Add solution under one of the following conditions.
a) After removal of plasma from freshly collected blood.
b) Within 8 hours of blood collection if components are prepared.
c) Within 72 hours of collection if blood is refrigerated immediately following collection.
16. Snap CLIKTIP (incline closure device) of primary collection bag and transfer plasma into satellite bag. Clamp transfer tubing of satellite bag.
17. Snap CLIKTIP of OPTISOL Solution bag and drain contents into primary bag containing red blood cells. Seal tubing of primary bag in two places, and cut between seals and separate from satellite bag(s).
NOTE: For TERUFLEX double bags, seal OPTISOL Solution bag tubing in two places, and cut between seals. Discard OPTISOL Solution container.
18. Invert the red cell- OPTISOL mixture several times to insure that the final AS-5 red cell product is well suspended.
19. Store AS-5 Red Blood Cells between 1-6 oC.
20. Infuse AS-5 Red Blood Cells within 42 days of collection.

For further processing, use standard component processing techniques.

To open the blister package, peel the cover film back 4/5 of its length.

After opening, unused bags may be stored for 30 days by returning cover film to original position and sealing with tape to prevent possible loss of moisture.

Image Figure Sealing with tape

CAUTIONS
• THE PACKET OF AGELESS CONTAINED IN THIS PACKAGE ABSORBS OXYGEN AND GENERATES HEAT ON REMOVAL AND SHOULD BE HANDLED WITH CARE.
• DISPOSE WITH PACKET IN TRAY.
• DO NOT DISPOSE WITH WASTES CONTAINING VOLATILE OR FLAMMABLE MATERIALS.
• DISCARD AGELESS PACKET WITHOUT OPENING.


TERUMO CORPORATION
44-1, 2-chome, Hatagaya, Shibuya-Ku, Tokyo, Japan
®: Registered Trademark

N-BB-OP-A (4)

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose Manufacturers


  • Terumo Corporation
    Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose (Cpd) And Optisol Red Cell Preservative (Anticoagulant Citrate Phosphate Dextrose (Cpd) And As-5 Red Cell Preservative) Kit [Terumo Corporation]
  • Terumo Corporation
    Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose (Cpd) And Optisol Red Cell Preservative (Anticoagulant Citrate Phosphate Dextrose (Cpd) And As-5 Red Cell Preservative) Kit [Terumo Corporation]

Login To Your Free Account